Clinical Trials on Vascular Anomaly

Total 51168 results

Deutsches Herzzentrum Muenchen

Unknown

Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery (ISAR-PEBIS)

Peripheral Vascular Disease

Germany
Stanford University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

L-Arginine in the Treatment of Peripheral Arterial Disease

Cardiovascular Diseases | Peripheral Vascular Diseases
Vessix Vascular, Inc

Terminated

Multicenter Assessment of the Safety and Efficacy of the Minnow Medical GRST™ Peripheral Catheter System

Peripheral Vascular Disease

Germany
W.L.Gore & Associates

Completed

GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study

Peripheral Vascular Diseases

United States
Pathway Medical Technologies Inc.

Completed

A Study to Collect Intravascular Ultrasound Images Before and After Treatment With the Jetstream System

Peripheral Arterial Disease | Peripheral Vascular Disease

United States
Hoffmann-La Roche

Unknown

A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery

Peripheral Vascular Disease

Ireland, Netherlands
Abbott Medical Devices

Completed

A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System (STRIDES)

Atherosclerosis | Peripheral Vascular Disease

Germany, Austria, Belgium, Italy
Arizona Heart Institute

Terminated

Prime Time for Superficial Femoral Artery (SFA) - The SFA Study (CLASE)

Peripheral Vascular Disease

United States
Cordis Corporation

Terminated

Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)

Peripheral Vascular Diseases

United States, China, Malaysia, India, Singapore
Hebei Medical University Third Hospital

Recruiting

The Research About the ACS After Femoropopliteal Arterial Injuries

Acute Compartment Syndrome

China
J&M Shuler

Completed

Ability of Near Infrared Spectroscopy to Isolate Compartments of the Extremity

Acute Compartment Syndrome

United States
Yale University

Recruiting

Mind Body Program Vascular

Peripheral Arterial Disease | Peripheral Vascular Diseases

United States
Second Affiliated Hospital of Soochow University

Recruiting

Clinical Study on the Effectiveness and Safety Evaluation of Directional Atherectomy Combined With Drug-coated Balloons (Remove)

Peripheral Vascular Diseases

China
University Hospital of Limerick
University of Limerick

Recruiting

The Mechanical Characterisation of Human Saphenous and Popliteal Vein

Peripheral Vascular Diseases

Ireland
W.L.Gore & Associates

Active, not recruiting

Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels (EXPAND)

Peripheral Vascular Diseases

Germany, Netherlands, France, Italy, Spain
Shockwave Medical, Inc.

Completed

Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+)

Peripheral Arterial Disease | Vascular Disease, Peripheral

New Zealand, Australia, United States
Ureca BV

Terminated

Safety and Efficacy of the URECA CTO Device

Peripheral Vascular Disease

Netherlands
Humacyte, Inc.
FGK Clinical Research GmbH

Active, not recruiting

Evaluation of the Safety and Efficacy of a Vascular Prosthesis as an Above-Knee Bypass Graft in Patients With PAD

Peripheral Arterial Disease | Peripheral Vascular Disease

Poland
SurModics, Inc.

Completed

Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon (PREVEIL)

Peripheral Arterial Disease | Peripheral Vascular Diseases

United States
Philips Clinical & Medical Affairs Global

Completed

Tack Optimized Balloon Angioplasty (TOBA) Study (TOBA)

Peripheral Vascular Disease

Belgium
VIVA Physicians
Medtronic

Completed

DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY)

Peripheral Vascular Disease

United States
John Paul II Hospital, Krakow

Unknown

Micronet Covered Stent in in Arterial Locations Beyond the Carotid Bifurcation - FLOW-Guard Study (FLOW-Guard)

Peripheral Vascular Diseases

Poland
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers

Peripheral Vascular Disease

Russian Federation
Abbott Medical Devices

Withdrawn

Popliteal Artery of Treatment With Balloon Angioplasty vs. SUPERA VERITAS Peripheral Stent System (PARADIGM)

Peripheral Vascular Disease
C. R. Bard

Completed

Bard® LifeStent® Vascular Stent Delivery System Study

Peripheral Vascular Disease

Austria, Germany
GlaxoSmithKline

Completed

3 Month PHI PAD PoM Study

Vascular Disease, Peripheral

United States
Abbott Medical Devices
Baim Institute for Clinical Research

Completed

Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery (SUPERB)

Peripheral Vascular Disease

United States
Medtronic Endovascular

Completed

The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions

Peripheral Vascular Disease

United States
Medtronic Endovascular
Medtronic

Completed

The Complete® Self-Expanding Stent and Stent Delivery System Registry

Peripheral Vascular Disease

United States
Northwestern University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])

Cardiovascular Diseases | Peripheral Vascular Diseases

United States
Cook Group Incorporated
William Cook Europe; MED Institute, Incorporated; Cook Japan Incorporated

Completed

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery (Zilver PTX)

Peripheral Vascular Diseases

United States, Japan, Germany
AtheroMed, Inc

Completed

Endovascular Atherectomy Safety and Effectiveness Study (EASE)

Peripheral Vascular Disease

United States, Germany
W.L.Gore & Associates

Completed

GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER) (VIPER)

Peripheral Vascular Diseases

United States
Celgene Corporation

Terminated

Prevention of Restenosis Following Revascularization

Vascular Disease, Peripheral

United States
University Hospital Tuebingen

Completed

Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

Peripheral Vascular Diseases

Germany
National Taiwan University Hospital

Unknown

The Burden of Peripheral Artery Occlusion Disease and Associated Factors in Peritoneal Dialysis Patients

Peripheral Vascular Diseases

Taiwan
Alexandria University
Harvard Medical School (HMS and HSDM); Joslin Diabetes Center; I-care Ophthalmology...

Recruiting

Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs

Diabetic Retinopathy | Diabetic Macular Edema | Retinal Disease

Egypt
PolyPhotonix Medical

Terminated

Noctura400 Treatment for Diabetic Retinopathy (CANDLE) (CANDLE)

Diabetic Macular Oedema

United Kingdom
Novartis Pharmaceuticals

Completed

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety (ZIPANGU)

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Japan
Santen SAS

Completed

Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

Diabetic Macular Edema

United States
Novartis Pharmaceuticals

Completed

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment (RELIGHT)

Diabetic Retinopathy | Macular Oedema

United Kingdom
Pfizer

Completed

Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema | Anti- VGF Inhibitor

Spain, United Kingdom, Finland, Sweden
Hanscom, Thomas, M.D.
Genentech, Inc.

Completed

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab (RAVEN)

Central Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein Occlusion

United States
Tokyo Medical University

Unknown

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion

Central Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein Occlusion

Japan
Genentech, Inc.

Completed

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Macular Edema | Retinal Vein Occlusion
Bayer
Regeneron Pharmaceuticals

Recruiting

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) (QUASAR)

Macular Edema Secondary to Retinal Vein Occlusion

Korea, Republic of, Japan, China, Lithuania, United States, Italy, Spain, Hungary, Israel, Portugal, Serbia, Poland, United Kingdom, Thailand, Czechia, Austria, Turkey, Australia, Bulgaria, Estonia, France, Georgia, Germany, Latvia, Mal... and more
Recens Medical, Inc.

Completed

Long Term Safety of Cooling Anesthesia for Intravitreal Injection (COOL-2)

Macular Degeneration | Diabetic Retinopathy | Diabetic Macular Edema | Macular Edema | Anesthesia, Local | Intravitreal Injection

United States
iRenix Medical, Inc.

Terminated

EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN) (CLEAN)

Diabetic Macular Edema | Branch Retinal Vein Occlusion | Glaucoma/Closed Angle Glaucoma

United States
Mayo Clinic

Completed

International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients (ICV-DME)

Diabetes With Diabetic Retinopathy With Macular Edema

United States
National Eye Institute (NEI)

Completed

Genetics and Markers of Degenerative and Inflammatory Eye Diseases

Uveitis | Diabetic Retinopathy | Age-Related Macular Degeneration (AMD)

United States

Clinical Trials on Vascular Anomaly

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations